With FDA nod on Uceris, Santarus puts out 'help wanted' sign for sales reps

Tools

Now that Santarus ($SNTS) has FDA approval in hand for its ulcerative colitis remedy Uceris, the company plans to staff up on the sales side, with 85 hires for its field force. Report

Filed Under